Washington biotech startups still able to capture capital

March 20, 2008

Washington may not have the nation's biggest biotech market, but startups still attract millions in venture capital. Geography isn't as much of a hurdle as the general competition for money.

Last year, the state saw 11 rounds of funding for biopharmaceutical companies totaling $253.4 million, according to MoneyTree Report data compiled by Thomson Financial for PricewaterhouseCoopers and the National Venture Capital Association.

Puget Sound Business Journal (Seattle) - by Robert Celaschi

Full Story: http://seattle.bizjournals.com/seattle/stories/2008/03/17/focus3.html?b=1205726400^1603687

***

Sen. Baucus Announces $28 Million Investment in Ligocyte Pharmaceuticals, Inc. of Bozeman, Montana http://matr.net/article-28279.html